ZA903015B - Therapeutic use of 5-ht3 receptor antagonists - Google Patents

Therapeutic use of 5-ht3 receptor antagonists

Info

Publication number
ZA903015B
ZA903015B ZA903015A ZA903015A ZA903015B ZA 903015 B ZA903015 B ZA 903015B ZA 903015 A ZA903015 A ZA 903015A ZA 903015 A ZA903015 A ZA 903015A ZA 903015 B ZA903015 B ZA 903015B
Authority
ZA
South Africa
Prior art keywords
receptor antagonists
therapeutic use
therapeutic
antagonists
receptor
Prior art date
Application number
ZA903015A
Inventor
Alberto Azcona
Azcona Alberto
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of ZA903015B publication Critical patent/ZA903015B/en

Links

ZA903015A 1989-04-21 1990-04-20 Therapeutic use of 5-ht3 receptor antagonists ZA903015B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898909147A GB8909147D0 (en) 1989-04-21 1989-04-21 Improvements in or relating to organic compounds

Publications (1)

Publication Number Publication Date
ZA903015B true ZA903015B (en) 1991-12-24

Family

ID=10655503

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA903015A ZA903015B (en) 1989-04-21 1990-04-20 Therapeutic use of 5-ht3 receptor antagonists

Country Status (2)

Country Link
GB (1) GB8909147D0 (en)
ZA (1) ZA903015B (en)

Also Published As

Publication number Publication date
GB8909147D0 (en) 1989-06-07

Similar Documents

Publication Publication Date Title
GR871212B (en) Therapeutic use of serotonin antagonist
GB9104598D0 (en) New use of 5 ht antagonists
GB8600783D0 (en) N-methyl-d-aspartate receptor antagonists
IL94963A0 (en) Use of polyamines as ionic-channel regulating agents
EP0488959A3 (en) New uses of competitive nmda receptor antagonists
GB8906168D0 (en) Therapeutic agents
GR900100015A (en) Dosage form for acalcium antagonist supply
GB2192001B (en) Melatonin antagonist
DK329289D0 (en) NEW THERAPEUTIC USE OF H2 RECEPTOR BREAKING COMPOUNDS
AU5627194A (en) New use of 5-ht3 receptor antagonists
ZA903015B (en) Therapeutic use of 5-ht3 receptor antagonists
ZA894097B (en) Alpha-adrenergic receptor antagonists
IL104821A0 (en) Novel 5-ht3 receptor antagonist
ZA898936B (en) Use of benzomorphanes for cytoprotection
GB8903740D0 (en) Therapeutic agents
GB8810509D0 (en) New use of dopamine receptor agonists
ZA893146B (en) Therapeutic use of serotonin antagonists
IE881220L (en) 5-ht3 receptor antagonists
GB9104599D0 (en) New use of 5 ht antagonists
GB8905130D0 (en) Therapeutic agents
IE892801L (en) Antagonists of 5-ht and 5-ht3 receptors
ZA9110088B (en) New use of quisqualate receptor antagonists
ZA892737B (en) Azabiocyclic compounds having 5-ht3 receptor antagonist activity
IE873198L (en) Ó-adreno receptor antagonists
IE891742L (en) Ó-adrenergic receptor antagonists